AN independent review of the
cost recovery arrangements for
Pharmaceutical Benefit Scheme
submissions has found that the
revenue from the program is
“significantly lower than
anticipated when the measure was
introduced”.
A committee was established in
Jul last year to look at the impact
cost recovery has had on the PBS,
and while concluding that overall
there is insufficient data available
to ascertain the impact, also
recommended that the costing
model be reevaluated “to ensure
that all costs associated with the
evaluation and listing processes are
included”.
The report, now available online
at www.pbs.gov.au, also noted a
number of fee exemptions and
waivers, and that about a third of
sponsors predicted an estimated
annual use of less than 2000 scripts
in the first 12 months of listing.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Sep 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Sep 12
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.